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Introduction
The complement system’s component C3 is the most abundant 
complement protein in blood and the central player in all three 
activation pathways (classical, alternative, and lectin). Comple-
ment engagement resulting in C3 cleavage to its biologically active 
fragments C3a (an inflammatory mediator) and C3b (an opsonin) 
is essential to innate immune protection from bacterial infections 
(1–3). C3 activation is traditionally thought to occur exclusively in 
the extracellular space.
Until the past few years, intracellular C3 activation was not 
considered. Several recent reports, however, have indicated a 
role for intracellular C3 in mediating key events for host defense 
and cell survival. Our group has described the presence of C3 
stores and intracellular C3 activation in human CD4+ T cells (4). 
In that study, C3a and C3b were generated from an intracellular 
C3 source, leading to cellular consequences, including cell activa-
tion and lineage development. Importantly, a correlation between 
hyperactive intracellular C3a generation and IFN-γ production by 
CD4+ T cells from autoimmune arthritis patients was demonstrat-
ed, indicating that dysregulated intracellular C3 activation is likely 
to play an important role in disease. Additionally, a role for intra-
cellular C3 has been highlighted recently in the literature through 
studies demonstrating that internalization of C3b-opsonized 
pathogens or cells can direct a proinflammatory immune response 
upon entering the intracellular milieu (5, 6). Apoptotic cells have 
been shown to internalize factor H (FH), which regulated endog-
enous intracellular C3 activation, resulting in enhanced apoptotic 
cell–surface opsonization. Also, the internalized FH complexed 
with nucleosomes and enhanced their clearance by phagocytes, 
thereby limiting inflammation (7).
The generation of C3a and C3b by human CD4+ T cells (8) 
is essential for the development of Th1 cell–mediated responses 
through autocrine stimulation of the C3aR and the complement 
membrane regulator CD46, respectively (9, 10). To further define 
the mechanism governing C3a and C3b generation by CD4+ T cells, 
Liszewski et al. (4) demonstrated that activation occurs inside the 
CD4+ T cell and that the processing into C3a and C3b is convertase 
independent, but cathepsin L (CTSL) dependent. Further, CTSL-
driven C3a generation is required for CD4+ T cell survival, and 
shuttling of C3a to the cell surface is necessary for Th1 effector 
cell differentiation and proinflammatory cytokine production (4). 
In a follow-up to this study, the Kemper group demonstrated that 
intracellular C3b generation (and autocrine CD46 stimulation) is 
required for metabolic reprogramming that allows Th1 cell activa-
tion and contraction (11). Further, this group suggested that such 
reprogramming also provides for a novel “complement-metabo-
lism-inflammasome” axis (12). Together, these studies establish 
an important role for intracellular C3 activation in normal CD4+ T 
cell immune function. Moreover, intracellular C3 stores are pres-
ent in many other cell types, suggesting this phenomenon may be 
of broad physiologic significance (4).
Despite growing evidence indicating the importance of intra-
cellular C3 stores in human T cell homeostasis (4, 8, 11, 12), the 
source and composition of these stores have not been rigorously 
investigated. Initially, we set out to characterize the composition 
of the intracellular C3 stores. Unexpectedly, we recognized a dif-
ference in the C3 species present in peripheral blood cells (PBCs) 
compared with cell lines by Western blotting (WB). Since a major 
distinction between cell lines and native cells is the time away 
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because under reducing conditions, the C3 α and β chains (Figure 
1A) were generated (14). This distinction between PBCs and their 
respective cell lines was not limited to B cells, but was true for 
several other PBCs tested, including CD4+ T cells versus Jurkat, a 
human T lymphocyte cell line (not shown). Therefore, PBCs con-
tain stores of native-like C3 that were not detected in cultured cell 
lines of related cell types by WB.
A major difference between PBCs and cultured cells is that the 
latter have not been exposed to a source of human C3 for many 
generations. We therefore hypothesized that PBCs may load C3 
from blood and/or synthesize and store C3. Consequently, Far-
age and ARPE-19, a human retinal epithelial cell line, were incu-
bated with 10% normal human serum (NHS) and assessed for C3 
by WB. As expected, Farage and ARPE-19 cell lines grown under 
standard culture conditions did not contain a detectable native-
like C3 band at 190 kDa (Figure 1B). However, consistent with our 
“loading” hypothesis, after a short exposure to 10% NHS, Farage 
and ARPE-19 cells demonstrated a band corresponding to C3 (Fig-
ure 1B), identical in Mr to C3 observed in primary B lymphocytes 
(see Figure 1A). The same results were observed whether these 
cell lines were exposed to plasma or whole blood (Supplemental 
Figure 1A; supplemental material available online with this article; 
https://doi.org/10.1172/JCI89412DS1).
To further assess whether C3 loads into cells, we incubated 
Farage cells with commercially available purified human C3. 
Similar to the results obtained with NHS, incubation with puri-
from a source of human C3, we hypothesized that cells may “load” 
C3 from the surrounding milieu.
In the current study, we demonstrate that one route of estab-
lishing intracellular C3 stores is uptake from the extracellular space 
via plasma. We characterize the C3 uptake process and show that 
this is a generalized phenomenon, not being limited to a specific 
or few cell types. Interestingly, we establish that cells specifically 
load C3(H2O), not native C3. In a process known as tickover, a small 
amount of C3 continuously activates in the fluid phase by hydroly-
sis of the internal thioester bond. If it does not covalently bind to a 
target within microseconds, C3(H2O) is formed (13). Here, we show 
that, following uptake, a majority of C3(H2O) loaded is returned to 
the cell exterior. Additionally, the C3(H2O) remaining provides an 
intracellular source of C3a. These results point to a C3(H2O) recy-
cling pathway being a major player in the intracellular complement 
system (ICS) that operates continuously in vivo.
Results
Human cell lines load C3 from an exogenous source. In experiments 
designed to further characterize the intracellular C3 stores identi-
fied in a previous publication (4), we observed by WB that human 
peripheral blood B lymphocytes (B cell) (Figure 1A) contained 
native-like C3. In contrast, Farage, a cell line derived from a 
human B cell lymphoma (Figure 1A), lacked detectable native-like 
C3 by WB (Figure 1A). This was not pro-C3, a single chain predom-
inantly pre-Golgi form that can be detected in cells secreting C3, 
Figure 1. Human cell lines demonstrate uptake of C3 from an exogenous source. (A) Whole 
cell lysates from peripheral blood B lymphocytes (B cell) and a human B cell line (Farage) 
were prepared and analyzed for C3 under reducing (R) and nonreducing (NR) conditions 
by WB. Lane 5 is a 4-fold longer exposure of lane 3. C3, 30 ng; C3b, 30 ng; B cells, 7.4 × 104 
cell equivalents; Farage, 6.3 × 105 cell equivalents. (B) Two human cells lines, ARPE-19 and 
Farage, were incubated in 10% NHS for 30 minutes to assess whether they take up C3. C3, 
30 ng; cell lysates, 2.4 × 105 cell equivalents. (C) Farage cells were incubated for 15 minutes 
with commercially available purified C3 and washed 3 (lane 3), 6 (lane 4), or 9 (lane 5) times 
prior to preparation of cell lysates. Cell lysates (top panel), final wash supernatants (bottom 
panel). C3, 30 ng; cell lysates, 2.4 × 105 cell equivalents; wash supernatants, 20 μl (of 100 μl). 
Representative blot of 4 (A and B) or 2 (C) independent experiments.
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tory. We detected minimal or no 
uptake of “fresh” C3 by Farage 
cells (Figure 2A). To further sup-
port the hypothesis that C3(H2O), 
but not native C3, is taken up, 
we compared the uptake effi-
ciency of commercially avail-
able C3 versus C3 inactivated 
by treatment with methylamine 
C3(H2O] analog, C3[MA] ref. 16). 
After incubation with 5 μg/ml of 
either C3 or C3(MA), Farage cells 
loaded approximately 10× more 
C3(MA) compared with C3, indi-
cating that cells were loading the 
thioester-inactivated fraction of 
the C3 (Figure 2B). Since a frac-
tion of the commercially avail-
able C3 is of the form C3(H2O), 
we used a lower concentration of 
C3 and C3(MA), as shown in Fig-
ure 2B, to ensure we would not 
reach saturation of loading with 
the C3 due to its percentage as 
C3(H2O). This would result in an 
inability to detect a difference in 
uptake compared with C3(MA). 
These data support the conclu-
sion that C3(H2O), not native C3, 
is preferentially loaded into cells. 
There is a dramatic conforma-
tional change upon tickover of 
C3 to C3(H2O) (17–19). Thus, and 
importantly, this points to uptake 
being mediated by a mechanism 
that specifically recognizes the 
conformation of C3(H2O).
To further characterize the specificity of C3(H2O) uptake, 
intracellular C3(H2O) loading by Farage and ARPE-19 cells was 
visualized by incubating cells with Dylight 488–conjugated C3 
(C3-DL488) and analyzed by confocal microscopy (Figure 3A). 
Following labeling of purified C3, C3-DL488, like C3(H2O), does 
not contain an intact thioester bond, as assessed by autolytic 
cleavage (Supplemental Figure 1B). ARPE-19 cells rapidly loaded 
the C3-DL488, and the uptake could be specifically inhibited in a 
dose-dependent manner by the addition of increasing concentra-
tions of unlabeled C3(H2O) to the culture media (Figure 2, C and 
D). We then heat denatured C3(H2O), which abrogated loading, 
pointing out that C3(H2O) uptake requires its 3D structure (Figure 
2E). We next showed that loading has species specificity in that 
human cell lines incubated with normal mouse serum did not take 
up mouse C3 (Supplemental Figure 1C). Taken with the preceding 
data demonstrating specificity of uptake for C3(H2O) compared 
with native C3, these results strongly suggest that C3(H2O) inter-
nalization occurs via a specific recognition system.
Intracellular location of C3(H2O). One common mechanism for 
internalization of a ligand is clathrin-coated pit–mediated endocy-
fied C3 demonstrated a C3-like band (Figure 1C). To check that 
the C3 detected is not secondary to carryover, we washed Farage 
cells 3, 6, or 9 times prior to preparing the lysates. The C3 did not 
dilute out of the lysates, even after it was undetectable in the wash 
supernatants (Figure 1C). Note that, as shown in Figure 1C, we 
employed a polyclonal Ab to C3a, which gives the same results as 
the goat anti-C3 pAb, i.e., the C3 in the cells contains C3a and this 
further establishes that it is native C3 and/or C3(H2O).
Cells specifically take up C3(H2O), not native C3. In a review of the 
literature, we located one report describing intracellular uptake of 
C3 by the α2-macroglobulin receptor (α2MR) (15). In that article, the 
α2MR was reported to specifically mediate uptake of C3(H2O). Under 
physiologic conditions, C3 turns over in blood at about 1% to 2% per 
hour to generate C3 with a cleaved thioester bond (13). Almost all 
of this transiently active C3 does not become bound to a target and 
therefore is inactivated by combining with H2O (C3[H2O]).
To determine whether C3(H2O) was the form being internal-
ized in our experiments, we compared uptake of commercially 
available C3 that has undergone several freeze/thaw cycles (gen-
erates more C3[H2O]) to that of C3 freshly prepared in our labora-
Figure 2. Loading of C3(H2O) is specific. Uptake of C3(H2O) versus native C3 was investigated by incubating 
Farage cells with (A) 20 μg/ml of a commercially available C3 preparation (C3) or a freshly purified C3 prepara-
tion (fresh C3) or (B) 5 μg/ml commercially available C3 or C3(MA). Cell lysates were prepared and analyzed for 
uptake by WB. GAPDH, loading control. C3, 20 ng (lane 1); cell lysates, 2.4 × 105 cell equivalents. (C) Labeled C3 
(C3-DL488) was utilized to visualize C3 loading into cells and determine whether uptake is sensitive to competi-
tion with unlabeled protein. ARPE-19 cells were loaded for 5 minutes without (top panel) or with (bottom panel, 
10-fold) 2-, 5-, or 10-fold excess concentrations of unlabeled C3(H2O) followed by C3-DL488 (50 μg/ml) for  
an additional 15 minutes and visualized by confocal microscopy. Original magnification, ×60. C3-DL488  
uptake per cell is quantified in part D. n = 3 representative cells per condition. Blue, DAPI; green, C3-DL488.  
*P < 0.05 compared with no excess of unlabeled C3(H2O) by 1-way ANOVA with Dunn’s multiple comparison 
test. (E) To determine whether denatured C3(MA) is internalized, Farage cells were incubated with 10 μg/ml 
C3(MA) or heat-denatured C3(MA) (hD-C3[MA]). C3, 30 ng (lane 1); cell lysates, 4 × 105 cell equivalents (lanes 
3–5). (A, B, and E) Blots are representative of 2 independent experiments.
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expressing fibroblasts and at all mAb concentrations used, we 
detected only a modest decrease (~15%) in C3(H2O) uptake (Fig-
ure 4B). Taken together, these data strongly support an α2MR-
independent mechanism of uptake.
We next sought to identify the receptor that mediates uptake. 
We considered several other candidate receptors and regula-
tory proteins, including complement receptors that bind C3b and 
C3(H2O). To competitively inhibit binding, we employed a strat-
egy in which we separately preincubated cells with a mAb to each 
protein prior to loading with C3(H2O). We evaluated uptake in 
cell lysates by WB. Specifically, we utilized mAbs to inhibit bind-
ing by CD46 (also known as membrane cofactor protein [MCP]), 
complement receptor 1 (CR1), complement receptor 2 (CR2), and 
complement receptor 3 (CR3) (Supplemental Figure 4, B and C). 
In addition to known C3b-binding proteins, we blocked sortilin, 
which shares common ligands with the LDLR gene family (i.e., the 
α2MR) (Supplemental Figure 4D). In each case, uptake occurred 
comparably to that in controls. Thus, the above candidate proteins 
are not responsible for C3(H2O) loading.
C3(H2O) recycles to the cell exterior. Because we noticed decreas-
ing quantities of C3(H2O) in PBCs, apparently depending on the 
length of time removed from a C3 source, we were interested in 
assessing how long such loaded C3(H2O) stores were maintained 
intracellularly. To establish C3(H2O)-loading parameters, we first 
investigated the magnitude of uptake. After a 1-hour incubation, 
Farage cells were saturated with approximately 15 ng of C3(H2O) 
per 105 cells (Figure 5A). Next, we investigated the time course of 
C3(H2O) uptake. Farage cells loaded C3(H2O) rapidly, with C3(H2O) 
detected in cell lysates after being exposed to C3(MA) for even 1 
minute (Figure 5B). To investigate the kinetics of loss, Farage cells 
(Figure 5C) and Jurkat cells (Figure 5E) were loaded with C3(H2O), 
washed, and plated onto FBS-containing culture media for the indi-
cated time points. At each time point, the supernatants were collect-
ed, and cell lysates were prepared and then analyzed by WB with a 
rabbit anti-C3a pAb. Although the kinetics varied by cell type, Far-
age (Figure 5C), Jurkat (Figure 5D), and ARPE-19 (Figure 5E) cells 
all demonstrated rapid depletion of the internalized C3(H2O) stores.
We next assessed whether the C3(H2O) loss was due to degra-
dation, release, or a combination thereof. The supernatants from 
tosis. This results in localization of the cargo into early endosomes. 
To follow the path of internalized C3(H2O), we performed a kinet-
ic evaluation of loading in ARPE-19 cells (Figure 3A) and CD4+ T 
cells (Supplemental Figure 2), utilizing C3-DL488, a marker for 
early endosomes (Rab5), and confocal microscopy. Immediately 
following exposure to C3-DL488 (<1 minute), the majority of the 
C3 was detected in a pattern suggesting association with the plas-
ma membrane. Within 15 minutes after loading, the C3-DL488 
colocalized to early endosomes, characteristic of clathrin-coated 
pit–mediated endocytosis. An hour after loading of C3-DL488, it 
no longer colocalized with Rab5 and a portion of the C3-DL488 
was lost, consistent with our subsequent results demonstrating 
recycling of the loaded C3(H2O) (see Figure 5G).
To augment the observation that C3(H2O) was internalized, 
we performed colocalization studies with surface marker CD46 
at 15 minutes after C3(H2O) loading. We did not detect colocal-
ization with the plasma membrane marker CD46, confirming 
the intracellular location of the loaded C3(H2O) (Supplemental 
Figure 3). Additionally, we performed flow cytometry with a goat 
pAb to C3 on freshly isolated CD4+ T cells and detected intracel-
lular C3(H2O), but minimal C3, on the plasma membrane (Figure 
3B). These data further establish that cell lines can rapidly “load” 
C3(H2O) from an exogenous source into the cell interior and, as 
the C3(H2O) is transferred into the cell, it migrates in early endo-
somes. In addition, the detection of C3(H2O) in primary human 
cells, but not cultured human cell lines, indicates that in vivo cells 
continually take up, store, and process C3(H2O) derived from plas-
ma and/or the interstitial milieu.
α2MR-independent uptake of C3(H2O). Since α2MR-mediated 
uptake of C3(H2O) by human fibroblasts has been previously 
reported (15), we evaluated its expression on the cell lines used in 
this study. Consistent with the literature, fibroblasts expressed the 
α2MR, while HUVECs did not (Figure 4A) (20). The ARPE-19 cell 
line expressed the α2MR at low levels (Figure 4A). Although Far-
age cells did not express the α2MR, they rapidly took up C3(MA), 
indicating that uptake is not mediated exclusively through this 
receptor. To characterize α2MR-mediated uptake on fibroblasts, 
the receptor was blocked with increasing concentrations of a mAb 
prior to adding C3(H2O) to the culture media. Even on α2MR-
Figure 3. C3 is localized to intracellular compartments following rapid uptake. (A) Representative confocal microscopy images showing that exogenously 
added C3 colocalizes to early endosomes. ARPE-19 cells were incubated with C3-DL488 (50 μg/ml, green) for 5 minutes, washed, and then incubated for 
an additional 1, 15, or 60 minutes in normal growth media. C3-DL488–loaded cells were washed, fixed, and permeabilized at the indicated time points 
and then stained for early endosomes (Rab5, red). Blue, DAPI. Representative images are from 3 independent experiments. Original magnification, ×60. 
(B) C3 is predominately intracellular in freshly isolated CD4+ T cells by flow cytometry. Ab, goat anti-C3. Gray and black histograms, isotype controls; red 
histogram, extracellular; blue histogram, intracellular. Representative of 5 independent experiments.
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C3(H2O) processing by cofactor proteins. Based upon our find-
ing, shown in Figure 5, demonstrating that cells take up C3(H2O), 
releasing approximately 80% intact and retaining approximately 
20%, we further explored the fate of the internalized/retained 
protein. Two possibilities were considered. First, the C3(H2O) 
could be inactivated and degraded similarly to the regulation of 
C3(H2O) that deposits on a cell membrane. In the latter case, inac-
tivation (i.e., iC3[H2O]) results from cofactor activity (CA) in which 
cleavage is mediated by plasma factor I (FI) along with a cofactor 
protein (such as CD46 on the cell surface or FH from the plasma). 
Consistent with this possibility, we observed cleavage fragments 
by WB in Farage cells incubated with purified C3 in the presence of 
C3-depleted serum for longer time periods (Supplemental Figure 
5). A second possible fate of internalized C3(H2O) would be as a 
source for the generation of C3a (similar to our earlier findings, 
ref. 4) by an intracellular protease such as CTSL.
To further examine the first possibility, we determined by 
WB that Farage cells do not possess endogenous stores of FH or 
FI (not shown). Next, we considered the possibility that FH and 
FI also might be taken up by cells, especially in light of a recent 
finding that apoptotic cells take up FH (7). Thus, we incubated 
purified components with cells and washed and performed WBs 
on cell lysates. FI was taken up by Farage cells (Figure 6A) by 
itself and when incubated with FH. FH also was taken up (Fig-
ure 6B). Analysis of subcellular fractions, prepared from Farage 
cells incubated with C3(MA), FH, and FI by WB, showed FH in 
the membrane and soluble nuclear fractions (Figure 6B). These 
are FH-like proteins, FH fragments, or crossreacting bands. Nota-
bly, we identified a putative nuclear localization sequence (NLS) 
spanning complement control proteins CCP1 and CCP2 in FH 
(LRKCQKRPCGH). By FACS analysis, FH was not observed on 
the cell membrane (not shown). Thus, we demonstrated FH and 
FI in Farage cell lysates after exogenous addition to cell cultures. 
Our results indicate that even nonapoptotic cells can take up not 
only FH, but also FI.
Next, we loaded Farage cells with C3(H2O) in the presence 
of FH and FI and found cleavage products in lysates consistent 
with CA. When Farage cells were incubated with C3(MA) alone 
or C3(MA) with FI, we detected no fragmentation, but rather the 
expected intact C3 α and β chains (Figure 6C), suggesting that 
CD46 expressed by Farage did not serve as a cofactor for FI-
mediated cleavage of loaded C3(MA). However, in the presence 
of loaded FI and FH, we observed C3(MA) cofactor–mediated 
cleavage. That is, incubation of all 3 with Farage cells resulted in 
the anticipated breakdown fragments, i.e., the α41 fragment and 
the C3a-retaining fragment that migrates at approximately 75 kDa 
(Figure 6C). These fragments are identical to purified iC3(H2O) 
(Figure 6, C and E). Since the WB employed goat Ab that does not 
distinguish the comigrating β chain (75 kDa) from C3a-α1 (72 kDa) 
the Farage cells described above were evaluated via WB. Interest-
ingly, an increase in C3 in the supernatant of Farage cells previ-
ously loaded with C3 roughly corresponded to the loss of C3 in the 
cell lysates (compare Figure 5F and Figure 5C). Supernatants from 
Farage cells not loaded with C3 contained much smaller amounts 
of C3 that were minimally, if at all, altered over time (Figure 5F), 
therefore establishing that C3 detected in supernatants from 
loaded cells was not derived from biosynthesis. Based on our find-
ings that Farage cells internalized approximately 15 ng/105 cells 
at saturation (Figure 5A) and secreted approximately 12 ng/ml of 
media/105 cells 24 hours after being removed from a C3 source, 
we concluded that unstimulated Farage cells secrete approximate-
ly 80% of the C3(H2O) and thus may have degraded or metabo-
lized up to approximately 20%.
To determine whether primary cells dissipated C3 stores in 
a time frame similar to that of cultured cells, CD4+ T cells were 
analyzed by WB for C3 after their removal from peripheral blood. 
Due to the time required to isolate CD4+ T cells (~3 hours), C3 loss 
at each time point cannot be directly compared with that of Jurkat 
cells (Figure 5D). However, in line with what was found with the 
latter, CD4+ T cells contained approximately 30% of the detect-
able C3 by 1 hour and approximately 5% by 24 hours (Figure 5G). 
These data indicate that both primary cells and cultured cell lines 
lost their C3(H2O) stores fairly rapidly upon removal from a C3 
source. This supports the concept that in vivo cells are homeostati-
cally internalizing, processing, and secreting C3(H2O).
Figure 4. α2MR-independent uptake of C3. (A) Analysis of α2MR expres-
sion on the indicated cell lines by flow cytometry. Gray-filled histogram, 
isotype control; red histogram, anti-α2MR. Results are representative of 2 
independent experiments. (B) The α2MR was blocked on fibroblasts with 
the indicated concentrations of anti-α2MR mAb (μg/ml) prior to incuba-
tion with 10% NHS (lanes 5–8). C3, 10 ng (lane 1); 2.4 × 105 cell equivalents 
(lanes 2–8). Results are representative of 3 independent experiments.
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(Figure 6C), we also probed the samples with rabbit anti-C3a poly-
clonal Ab and verified the presence of C3a-α1 (Figure 6C).
The requirement for addition of exogenous FH and FI for CA 
suggested that cultured Farage cells do not synthesize or contain 
endogenous stores of these proteins that are accessible to the load-
ed C3(H2O). A time course of C3(H2O) α chain degradation indi-
cated that no cleavage of C3(MA) occurs unless FH and FI are also 
loaded (Figure 6D). Further, CA begins quickly (~1 minute) and is 
completed by 30 minutes. These studies were also performed with 
fibroblasts, and the same results were obtained. These data indi-
cate that cells take up FH and FI and that these proteins then can 
mediate intracellular cleavage of the loaded C3(H2O).
C3a is generated from loaded C3(H2O) and is augmented by cell 
activation. In addition to degradation by CA, a second fate of 
loaded C3(H2O) is to contribute to the generation of C3a. Since 
previous reports described the intracellular generation of C3a (4, 
11), we examined whether C3a was generated following uptake 
from C3(H2O). Intracellular C3a was detected in resting Farage 
cells by 15 minutes after exposure to NHS, and its generation 
progressively increased over 2 hours (Figure 7A). C3a generation 
from loaded C3(H2O) could be detected in multiple cell types (not 
shown). Although we could not detect C3a generation by WB in 
the absence of uptake, previous studies have detected a scant 
amount of C3a via flow cytometry from intracellular stores in cells 
not exposed to C3(H2O) (4). This indicates that there are 2 sources 
of intracellular C3 stores, i.e., C3a can be generated after uptake 
of C3(H2O) from blood or from synthetic C3 stores. In agree-
ment with the latter, we detected C3 mRNA in a survey of cell 
lines (Supplemental Figure 6). In addition, C3a generation was 
observed following uptake of purified C3(MA), indicating that it 
Figure 5. Characterization of C3(H2O) recycling. (A) The amount of C3(H2O) uptake was assessed by WB and quantified by densitometry. Farage cells 
were incubated for 1 hour with increasing concentrations of C3(MA) in 10% C3-depleted serum. Densitometry was used to determine ng of C3(MA) taken 
up per 105 cell equivalents. (B) The kinetics of loading were determined by incubating Farage cells with 5 μg/ml C3(MA) for increasing lengths of time and 
analyzed by WB. Densitometry was used to assess the amount of C3(H2O) present in the cells at each time point. Inset is a representative WB. (C–E) The 
kinetics of C3(H2O) loss from established stores was assessed in Farage (C), Jurkat (D), and ARPE-19 (E) cells. Cells were incubated for 1 hour with 20 μg/ml 
C3, washed, and plated in the absence of C3 (normal growth media) for the indicated time points. Densitometric scanning of WB was used to determine 
the amount of C3(H2O) remaining in the cells compared with cells lysed immediately after loading. (F) The amount of C3(H2O) released from loaded (C3 
loaded) or unloaded (unloaded) Farage cells into the supernatant was assessed by WB at the indicated time points. (G) The kinetics of C3(H2O) loss from 
freshly isolated CD4+ T cells that contained C3(H2O) stores loaded in vivo was assessed. The isolated CD4
+ T cells were plated in complete media containing 
10% FBS and 25 U/ml rhIL-2, and cell lysates were prepared at the indicated time points. Densitometric scanning was used to determine the amount of 
C3(H2O) remaining in the cells compared with cells lysed immediately after isolation. (A–G) Data (mean ± SD) are from 2 independent experiments.
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is due to intracellular cleavage and not a result of other serum fac-
tors or convertase activity (not shown). As further evidence for 
the conclusion that uptake is not convertase dependent, we show 
uptake in the presence of EDTA (Supplemental Figure 7).
To extend this observation and examine biological relevance, 
we asked whether C3a generation from loaded C3(H2O) was mod-
ulated in activated cells. Farage cells were incubated on anti-IgM–
coated or BSA-coated (nonactivated control) plates for 3 hours in 
the presence of 10% NHS. The resulting cell lysates were analyzed 
for C3a generation by WB with a rabbit pAb to C3a. Compared 
with nonactivated controls, C3a generation significantly increased 
in activated Farage cells (Figure 7B). This points to a potentially 
important role for C3(H2O) uptake and subsequent C3a genera-
tion in B cell activation and function.
To determine whether this phenomenon is of broader signifi-
cance, we investigated C3a generation by activated CD4+ T cells. 
CD4+ T cells were incubated for 3 hours on anti-CD3/CD46–
coated or MOPC-31–coated (nonactivated control) plates in the 
presence of 10% NHS. C3a generation was evaluated by WB with 
a rabbit pAb to C3a. As with the Farage cell line, C3a generation 
significantly increased in activated CD4+ T cells compared with 
nonactivated controls (Figure 7C), and in the absence of NHS, 
C3a generation was not detectable by WB (not shown). Therefore, 
the observed increase in C3a generated under activating condi-
tions was from loaded C3(H2O). A CTSL-dependent mechanism 
for generation of C3a from intracellular C3 stores in CD4+ T cells 
has been previously described (4), representing one mechanism 
for generation of C3a from loaded C3(H2O). In support of this, 
we have demonstrated generation of C3a from C3(MA) by CTSL 
in vitro (Supplemental Figure 8A). Additionally, we showed more 
efficient cleavage of C3(MA) compared with native C3 by CTSL in 
vitro (Supplemental Figure 8B). Since the protease responsible for 
C3a generation from C3(H2O) is likely cell type specific, we also 
demonstrated cleavage of C3(H2O) by elastase (Supplemental Fig-
ure 8C) and granzyme B (Supplemental Figure 8D).
C3(H2O) uptake modulates CD4+ T cell cytokine production. 
Previous work has demonstrated that shuttling of intracellular-
generated C3a (with the C3aR) to the cell surface results in a pro-
Figure 6. C3(H2O) processing by 
cofactor proteins. Whole cell 
lysates (A and B) and subcel-
lular fractions (B) were prepared 
from Farage cells incubated 
with C3(MA), with or without 
FH and FI, and analyzed by WB 
with a goat anti-FI pAb (A) or a 
goat anti-FH pAb (B). Nonreduc-
ing conditions. FH, 20 ng; cell 
equivalents, 3 × 105. Representa-
tive of 2 independent experi-
ments. (C) Farage cells were 
incubated for 15 minutes with 15 
μg/ml C3(MA) alone or plus FI (I) 
(2 μg/ml), or FI and FH (H) (25 
μg/ml). The resulting cell lysates 
were analyzed by WB with a goat 
anti-C3 pAb (top panel) or a rab-
bit anti-C3a pAb (bottom panel). 
Under reducing conditions. C3, 
iC3b and iC3(MA), 20 ng; cell 
lysates, 4 × 105 cell equivalents 
loaded. Representative of 3 
independent experiments. (D) 
Lysates prepared from Farage 
cells incubated with C3(MA) 
alone or with FH and FI for the 
times indicated were analyzed 
for uptake and CA by WB with a 
rabbit anti-C3a pAb. Reducing 
conditions. C3, 70 ng; C3a, 30 ng; 
cell lysates, 4 × 105 cell equiva-
lents loaded. Representative of 
2 independent experiments. (E) 
Schematic depicting the cleav-
age and inactivation of C3(H2O) 
resulting from CA. These experi-
ments were also performed with 
fibroblasts, and the same results 
were obtained.
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not native C3. These 2 proteins differ primarily but strikingly in 
conformation (17–19). Additionally, uptake of labeled C3(H2O) was 
competitively reduced/inhibited with unlabeled protein. Further, 
we have demonstrated that denatured C3(H2O) was not taken up, 
suggesting that recognition of its 3D structure is essential. Also, 
mouse C3(H2O) was not loaded into human cell lines, indicating 
that this process is species specific. C3(H2O) was located in a plas-
ma membrane–associated pattern within 1 minute of exposure 
and then colocalized with early endosomes by 15 minutes after 
loading. Finally, uptake was a rapid and saturable process. Our 
next goals include identifying the receptor and further elaborating 
the intracellular handling and processing of internalized C3(H2O).
To our knowledge, only one previous report has described cel-
lular uptake of C3(H2O) (15). This article suggested that uptake of 
C3(H2O) is a means for its clearance — in other words, a straightfor-
ward degradation pathway. However, C3(H2O) is not inert. First, it 
can combine with factor B (FB) to initiate an alternative pathway 
(AP) feedback loop (cleavage of C3 and C5 via C3 and C5 con-
vertases, respectively). Second, it can be proteolytically modified 
(both intracellularly and extracellularly) to liberate C3a and prob-
ably other C3 α and β chain fragments with biological activity (22). 
Here, we demonstrate that this uptake allows for recycling of the 
C3(H2O), provides a source of C3a, and affects cell activation phe-
nomena. In agreement with the report by Meilinger et al. (15), we 
show that cells specifically internalize C3(H2O) and not native C3.
In contrast with Meilinger et al. (15), we did not find that 
uptake is mediated exclusively through the α2MR. We showed 
this by 2 methods. First, human cell lines that do not express the 
α2MR still loaded C3(H2O). Second, blocking this receptor uti-
lizing α2MR-expressing human fibroblasts did not substantially 
abrogate uptake of C3(H2O). Notably, the dominant binding pro-
tein identified in the plasma membrane fraction by Meilinger 
et al. (15) was an unidentified approximately 80-kDa species, not 
the α2MR. This supports our results showing that an unidentified 
receptor mediates uptake of C3(H2O) in human cells, either alone 
or in conjunction with the α2MR.
Additionally, much of the work by Meilinger et al. (15) was 
performed in rodents, whereas we have focused exclusively on 
human cells (15). In a single experiment using human fibroblasts, 
they demonstrated that receptor-associated protein (RAP), a pro-
tein that impairs binding to the α2MR, blocked C3(H2O) uptake. 
However, RAP does not exclusively block binding to the α2MR 
(23), and other binding partners of RAP are potential candidate 
receptors mediating uptake in human fibroblasts. Further, block-
ing of candidate receptors CD46, CR1, CR2, and CR3 did not 
reduce binding. Taken together, these data suggest that C3(H2O) 
inflammatory phenotype (IFN-γ production) by CD4+ T cells (4). 
Since we detected C3a generation from loaded C3(H2O) that was 
increased following CD4+ T cell stimulation (Figure 7C), we inves-
tigated the effect of C3(H2O) uptake on Th1/Th2 cytokine produc-
tion by stimulated CD4+ T cells. We costimulated CD4+ T cells 
via the T cell receptor (mAb OKT-3) and CD46 (mAb TRA-2-10) 
in the presence/absence of C3(H2O) and assessed production of 4 
cytokines involved in the Th1 response or contraction. We detected 
induction of IL-6 in the presence of C3(H2O) uptake that was sig-
nificantly augmented by crosslinking the T cell receptor (Figure 8). 
This result was specific for C3(H2O), as purified C3b did not aug-
ment IL-6 production. These data highlight one example of how 
the C3(H2O) recycling pathway contributes to immune defense. 
The generation of IL-6, a cytokine with pleiotropic effects, could 
influence immune responses as well as regulate metabolic and 
regenerative processes (21). Thus, our data suggest the importance 
of evaluating the impact of soluble plasma factors when perform-
ing in vitro studies assessing cellular immune function.
Discussion
Processing of C3 into the activation fragments C3a and C3b was 
traditionally thought to occur predominately if not exclusively in 
the extracellular space. A recent report by our group in collabora-
tion with the Kemper laboratory demonstrated intracellular C3 
activation from C3 stores in human cells by a convertase-indepen-
dent process (4). However, in this report, the source of the intra-
cellular C3 stores was not examined. Herein we provide evidence 
that one route of establishing these C3 stores is through intracel-
lular loading from blood. We also describe the C3(H2O) uptake 
process and its recycling to the extracellular milieu in several cell 
types, suggesting that this process is of broad significance.
Our results are consistent with a specific, receptor-mediated 
mechanism. This was evident by exclusive uptake of C3(H2O) and 
Figure 7. Intracellular C3a generation from loaded C3(H2O) is augmented 
following cell activation. (A) Cell lysates from Farage cells incubated in 
10% NHS for the indicated time points were analyzed for C3a generation by 
WB. To determine whether cell activation modulates C3a production, Far-
age cells (B) were incubated on anti-IgM– or BSA-coated plates or CD4+ T 
cells (C) were incubated on anti-CD3/CD46– or MOPC-31–coated plates for 3 
hours in the presence of 10% NHS. The resulting cell lysates were assessed 
for C3a production by WB. Densitometric scanning of C3a production is 
expressed as mean ± SD in bottom panels. n = 3–4 from at least 2 inde-
pendent experiments. *P < 0.05, 2-tailed Student’s t test. (A–C) Reducing 
conditions. C3a, 30 ng; cell lysates, 2 × 105 cell equivalents loaded.
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C3(H2O), FH, and FI are internalized and produce iC3(H2O). Sub-
sequently, C3a and other fragments can be released from iC3(H2O) 
by intracellular proteases and become available for immune mod-
ulation and effector functions (see Supplemental Figure 9). Fur-
ther clarifying the intracellular processing of C3(H2O) is a current 
area of investigation in our laboratory.
To our surprise, a large fraction of the C3(H2O) taken up by 
multiple cell types was returned to the media. It did not appear to 
be modified, as the Mr was identical to that of C3(H2O) and C3a 
and the β chain remained attached. These data are therefore con-
sistent with a C3-recycling pathway involving C3(H2O). This satu-
rable pathway likely operates continuously in vivo (see Supplemen-
tal Figure 9). We believe this is a novel pathway of C3 metabolism 
that operates in many (if not most) cell types, as we demonstrated 
in PBCs and a variety of cultured cell lines. Our hypothesis is that 
cells take advantage of this source to trigger not only intracellular 
but also interstitial recognition events that lead to cell activation 
phenomena and result in enhanced proinflammatory and survival 
phenotypes. There are several biological advantages for such a sys-
tem. First, this represents a source of C3a that is required for Th1 
differentiation in CD4+ T cells (4, 29). Second, although C3(H2O) 
lacks a reactive thioester and therefore cannot covalently attach 
to a pathogen, it can serve as the nidus to initiate the AP feedback 
loop to generate a C3 convertase. Such a process could enhance 
the recent observation that pathogens opsonized with C3 extracel-
lularly and then gain entrance into the cell interior, where they can 
activate an inflammasome pathway (6). These previous studies 
were performed in the absence of a source of human complement 
and therefore did not take into account C3(H2O) loading. Indeed, 
we speculate that in the presence of a source of C3(H2O), cells that 
are challenged with an intracellular pathogen will respond more 
rapidly and vigorously.
Herein, we report that C3a production occurs from C3(H2O) 
following uptake. Additionally, we show that C3a production from 
loaded C3(H2O) is increased under activating conditions in both 
human CD4+ T cells and the human B cell line Farage, supporting 
the concept that this uptake process plays an important role in cel-
lular responses. The significance of intracellular C3a generation is 
underscored by previous work from our group showing that CD4+ 
T cells from autoimmune arthritis patients had an increased gen-
eration of C3a (as compared with healthy controls) due to an over-
active ICS and that this correlated with an increased Th1 response 
(4). Importantly, our results establish that C3(H2O) uptake by 
CD4+ T cells alters the induced cytokine profile. Specifically, we 
demonstrate IL-6 production that is significantly (Figure 8, P < 
0.01) augmented by CD3 crosslinking in the presence of C3(H2O). 
Our results, combined with previous work establishing the impor-
has additional receptors on the plasma membrane responsible for 
mediating its uptake. Identifying the receptor or receptors will be 
a focus of ongoing studies.
While FH uptake by apoptotic cells has recently been report-
ed (7), we discovered that, in addition to C3(H2O), healthy cells 
also load FH. Despite synthesis and storage of FH in certain cell 
types (24–27), we did not detect stores in the Farage cell line pri-
or to exposure to a source of FH. Interestingly, after subcellular 
fractionation of Farage cells loaded with FH, we detected it in the 
soluble nuclear fraction. We also identified a putative NLS span-
ning the first and second repeats of FH. This result is in line with a 
recent report demonstrating FH binding to nucleosomes of apop-
totic cells (7). Whether this predicted NLS mediates FH nuclear 
targeting and additional roles of FH in the nucleus are interesting 
areas for investigation. Notably, another member of the RCA- 
containing protein family, CD46, also contains a NLS in its cyto-
plasmic tail and targets to the nucleus (11, 28).
In addition to demonstrating FH uptake by normal cells and 
cell lines, we discovered that the same cell populations load FI. 
This plasma serine protease is required for FH or CD46 to medi-
ate CA. In line with this finding and following internalization, FH 
and FI function inside the cell in processing of loaded C3(H2O). 
Thus, FH and FI cleaved the C3(H2O) α chain to produce iC3(H2O) 
(see Figure 6, A and E). It has been reported that C3a can be lib-
erated from C3(H2O) by both trypsin and the C3 convertase (22). 
Although this cleavage mediated by a C3 convertase was less 
efficient than from the native C3, we show that CTSL, a physi-
ologically relevant intracellular protease, cleaves C3(H2O) more 
efficiently that native C3 (Supplemental Figure 8B). Intracellu-
larly, we hypothesize that C3a production could occur from both 
C3(H2O) and iC3(H2O). We speculate that C3a may be liberated 
more efficiently from iC3(H2O) compared with C3(H2O), provid-
ing one possible role for FH and FI loading. This role of loaded FH 
is supported by the results of Martin et al., who demonstrated that 
apoptotic cell–loaded FH enhanced CTSL-mediated endogenous 
C3 cleavage (2016, ref. 7). These data point to a process whereby 
Figure 8. C3(H2O) uptake modulates the cytokine profile of activated 
CD4+ T cells. Supernatants from CD4+ T cells incubated for 18 hours on 
anti-CD3– (mAb OKT-3), anti-CD46– (mAb TRA-2-10), anti-CD3 plus anti-
CD46–, or nonactivated-coated (NA) (MOPC-31) plates in the presence of 
C3(H2O), C3b, or media only were assessed for IL-6, IFN-γ, TNF, and IL-10  
by CBA. Experiments with C3b were only performed with NA and α-CD3+ 
α-CD46 activated cells. Data are expressed as mean ± SEM. n = 6 from  
2 healthy donors in 2 independent experiments run in triplicate.  
***P < 0.001 by 1-way ANOVA with Bonferroni’s multiple comparison test.
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Methods
Cell lines, Abs, and proteins. The Farage human B cell lymphoma and 
Jurkat human T cell leukemia cell lines (ATCC) were grown in RPMI 
1640 with 10% heat-inactivated FBS, 100 units/ml penicillin, and 100 
μg/ml streptomycin. The ARPE-19 retinal epithelial cell line (ATCC) 
was grown in DMEM:F12 with 10% heat-inactivated FBS, 100 units/
ml penicillin, and 100 μg/ml streptomycin. Primary dermal fibroblasts 
(ATCC) were grown in basal medium supplemented with the Fibro-
blast Growth Kit–Low serum (ATCC). Human HUVECs (ATCC) were 
grown in vascular cell basal medium supplemented with the Endo-
thelial Cell Growth Kit (ATCC). All cell lines were maintained at 37°C 
in 5% CO2. Rabbit anti-human C3a (A218) and goat anti-human C3 
(A213) pAbs were obtained from Complement Technologies. Chicken 
anti-human C3 (GW20073F) pAb was from Sigma-Aldrich.
Purified human C3 was generated in house (38) or purchased 
from Complement Technologies (A113). Purified human C3b (A114), 
C3a (A118), FH (A137) and FI (A138), and C3-dpl serum (A314) were 
purchased from Complement Technologies. The anti-α2MR mAb 
(MA-8G1) used for flow cytometry and blocking experiments was pur-
chased from Molecular Innovations. Ab for B lymphocyte activation 
(goat F[ab′]2 anti-human IgM, 2022-01) was purchased from South-
ernBiotech. Abs for CD4+ T cell stimulation were generated in house 
(anti-CD3, OKT-3 or anti-CD46, TRA-2-10) (39).
Isolation and activation of human lymphocytes. Primary human 
lymphocytes were isolated from whole blood samples. B lymphocytes 
were isolated from PBCs using MACS B Cell Isolation Kit II (Miltenyi 
Biotec). CD4+ T cells were isolated with the EasySep Human CD4+ T 
cell Isolation Kit (StemCell Technologies). CD4+ T cells (1 to 1.5 × 105 
cells/well) were activated for 3 hours in the presence of 10% NHS or 
10% FBS on 96-well culture plates coated with Abs to CD3 and CD46 
(2 μg/ml). Cytokine production by activated CD4+ T cells was assessed 
by the BD Cytometric Bead Array (CBA) Human Th1/Th2 Cytokine 
Kit II. Farage B cells (1 to 1.5 × 105 cells/well) were activated for 3 hours 
in the presence of 10% NHS or 10% FBS on 96-well culture plates 
coated with anti-IgM (10 μg/ml).
Cell lysate preparation. Cell lysates were prepared by resuspending 
cell pellets in cell lysis buffer (1% NP-40, 0.05% SDS, in PBS) with 2 mM 
PMSF and ProteaseArrest (G-Biosciences) and incubating for 20 min-
utes on ice. The resulting lysates were then centrifuged for 10 minutes 
at 11,200 g and supernatants collected, aliquoted, and stored at –80°C.
Methylamine and denaturing treatments. C3 was treated with 
methylamine to hydrolyze the thioester bond and termed C3(MA) (16, 
40). Briefly, purified C3 was incubated with 0.4 M methylamine hydro-
chloride (Sigma Aldrich) and 0.1 M Tris pH 8.0 for 1 hour at 37°C. To 
denature C3(MA), an aliquot was heated at 85°C for 2 minutes.
C3 loading and loss. For C3 loading, 2 × 106 cells/ml were resus-
pended in serum-free medium containing 20 μg/ml C3(MA) (unless 
otherwise indicated). Cells were routinely incubated for 15 minutes 
at 37°C. Following incubation, cells were washed 3× with PBS. For C3 
loss experiments, after loading, washed cells were plated in 48-well 
culture plates at 2 × 106 cells/ml in normal growth media containing 
10% FBS and incubated for indicated times before the supernatants 
were collected, cell pellets washed, and cell lysates prepared. The 
C3 content of the cell lysates and supernatants was analyzed by WB. 
Briefly, samples were electrophoresed in reduced or nonreduced 
4%–20% SDS-PAGE buffer (unless indicated otherwise), transferred 
to nitrocellulose, and probed with rabbit anti-human C3a (A218) or 
tance of intracellular C3a in immune defense and homeostasis, 
point to an essential role for C3(H2O) uptake and processing in 
the immune response. Further, generation of IL-6 could affect 
processes ranging from inflammation to metabolic reprogram-
ming (21). Highlighting the importance of IL-6 in regulation of 
the immune response, the dysregulated production of IL-6 plays 
a pathological role in several autoimmune diseases. Further, a 
humanized IL-6 receptor Ab, tocilizumab, is therapeutically ben-
eficial in several inflammatory diseases, including rheumatoid 
arthritis and Castleman’s disease (reviewed in ref. 30). It has been 
previously suggested from studies in Il6–/– and C3–/– mice that IL-6 
and C3 are linked in regulation of germinal center development 
and Ab production (31), and our current results provide additional 
mechanistic insight into this process. In view of the multiple pos-
sible effects of the induced IL-6, a more in-depth investigation is 
underway to explore this phenomenon.
Currently, most in vitro cell activation studies reported in the 
literature have been performed in traditional media containing 
10% FCS, and therefore, no human C3(H2O) was available for 
uptake and intracellular processing. Additionally, other plasma 
components may be required to maintain cellular homeostasis or 
participate in cell activation phenomena. A role for soluble plasma 
factors should be considered when performing in vitro studies 
assessing cellular activation phenomena on cells isolated from 
blood prior to study.
Although we have shown that C3(H2O) uptake and processing 
occurs in many cell types, it is clear that an additional source of C3 
is present within human cells. This is evident by the fact that intra-
cellular C3 stores have been identified in C3-deficient individuals 
(4, 32–35) as well as in cell lines that have been long removed from 
a C3 source (4). One potential source, of course, is biosynthesis and 
storage of C3. In agreement with this, we demonstrated C3 mRNA 
in the cell lines examined (Supplemental Figure 6). Although most 
C3 is secreted, it has been shown that some cell types store C3, 
such as human neutrophils (36) and monocytes (37). The deriva-
tion and composition of these C3 stores have not been delineated. 
Whether these stores have overlapping or distinct roles from those 
established by C3(H2O) loading requires further investigation.
In retrospect, as we sought to understand the biologic func-
tion of C3(H2O) uptake, we considered the simple concept that 
C3(H2O) could be the original gateway to activation of the comple-
ment system in cells, on membranes and in the interstitium. In this 
scenario, a putative key innate immune role for C3(H2O) uptake 
into intracellular C3 stores is to assist in a rapid response of the 
host to danger. Thus, the C3 species within the cell and in the inter-
stitium is readily available to generate C3a and other fragments to 
initiate substantial and rapid local complement activation at a site 
of injury or pathogen invasion. Indeed, such a mechanism could 
have been one of the earliest and quickest innate immune defens-
es developed, an adaptive remnant retained in modern times.
Finally, our data and other recent investigations now broad-
en the role of the newly discovered ICS (4, 11). The finding of a 
C3(H2O)-recycling pathway has important implications for our 
understanding of basic processes the cell utilizes for homeostasis 
and defense. These data may also suggest potential new thera-
peutic targets and strategies. We are just beginning to unravel this 
complex, intriguing, and important new system.
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Statistics. All data were subjected to statistical analysis using 
Prism Software version 5 (GraphPad). Comparisons between 2 groups 
were performed by 2-tailed Student’s t test (parametric). Compari-
sons between multiple groups were performed using a 1-way ANOVA 
with Bonferroni’s multiple comparison test (parametric) or Dunn’s 
multiple comparison test (nonparametric). A P value of less than 0.05 
was considered significant.
Study approval. Blood was collected from healthy donors after 
written informed consent according to the guidelines of the WUSM 
Human Studies Committee.
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goat anti-C3 (A213) pAbs (Complement Technologies), followed by 
appropriate HRP-conjugated secondary Abs. Blots were visualized on 
a ChemiDoc XRS Imager (Bio-Rad).
FH and FI loading. Similarly to what occurred in the C3 studies, 
25 μg/ml FH and/or 4 μg/ml FI were added to the medium of cells 
plated at 2 × 106 cells/ml. After 15 minutes at 37°C incubation and 
washing (3×) with PBS, the FH and FI concentrations in cell lysates 
were analyzed by WB with a goat anti-FH (A237) pAb or a goat anti-FI 
(A238) pAb (Complement Technologies).
Enzymatic reactions. Recombinant CTSL (R&D Systems) was acti-
vated according to the manufacturer’s instructions. In vitro cleavage of 
C3(MA) and C3 by CTSL was performed by incubating 500 ng C3(MA) 
or C3 with 2 ng or 300 ng CTSL for 1 hour at 37°C. In vitro cleavage by 
elastase (EPC Elastin Products Inc.) was performed by incubating 1 μg 
C3(MA) with increasing concentrations of elastase (0–1.3 μg/ml) for 
1 hour at 37°C. In vitro cleavage by granzyme B (Enzo Life Sciences) 
was performed by incubating 50 ng C3(MA) with 50 ng/ml granzyme 
B for 1 hour at 37°C. Cleavage fragments were visualized by WB.
Confocal microscopy and colocalization analysis. Confocal micros-
copy was performed as previously described (4). Briefly, fixed and 
permeabilized cells were stained with primary Abs for 30 minutes at 
room temperature (RT). Staining with secondary Abs was performed 
by incubation for 30 minutes at RT. Cells were mounted with ProLong 
Gold (Thermo Fisher) and incubated at 4°C overnight. For studies 
using fluorescent dye–conjugated C3, the C3 was labeled with Dylight 
488 using the Dylight 488 Antibody Labeling Kit (Thermo Fisher). 
This labeling kit reacts with exposed N-terminal α amino groups or 
the ε amino groups of lysine residues to form stable amide bonds. 
Following labeling, the C3 is of the form C3(H2O) (see Supplemental 
Figure 1B). For colocalization studies, the Cellular Localization IF Ab 
Sampler Kit (catalog 4753, Cell Signaling) was employed. Images were 
obtained in the Imaging Facility, Department of Molecular Microbi-
ology, WUSM, by confocal fluorescence microscopy. Samples were 
visualized with a Zeiss LSM880 with Airyscan laser scanning confocal 
microscope (Carl Zeiss Inc.) equipped with a 63×, 1.4 numerical aper-
ture Zeiss Plan Apochromat oil objective.
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